McGrath S - Search Results

1

The prognostic significance of specific HOX gene expression patterns in ovarian cancer.

Kelly Z, Moller-Levet C, McGrath S, Butler-Manuel S, Kavitha Madhuri T, Kierzek AM, Pandha H, Morgan R, Michael A. Kelly Z, et al. Among authors: mcgrath s. Int J Cancer. 2016 Oct 1;139(7):1608-17. doi: 10.1002/ijc.30204. Epub 2016 Jun 14. Int J Cancer. 2016. PMID: 27225067

2

Low grade serous ovarian carcinoma with metastases to the sternum and ribs.

McGrath S, Madhuri TK, Susarla S, Haagsma B, Saleh F, Michael A. McGrath S, et al. Pathology. 2012 Aug;44(5):481-2. doi: 10.1097/PAT.0b013e3283559d7d. Pathology. 2012. PMID: 22744167 No abstract available.

3

Engrailed homeobox transcription factors as potential markers and targets in cancer.

McGrath SE, Michael A, Pandha H, Morgan R. McGrath SE, et al. FEBS Lett. 2013 Mar 18;587(6):549-54. doi: 10.1016/j.febslet.2013.01.054. Epub 2013 Feb 7. FEBS Lett. 2013. PMID: 23395604 Free article. Review.

4

EN2: a novel prostate cancer biomarker.

McGrath SE, Michael A, Morgan R, Pandha H. McGrath SE, et al. Biomark Med. 2013 Dec;7(6):893-901. doi: 10.2217/bmm.13.115. Biomark Med. 2013. PMID: 24266821 Review.

5

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer.

Annels NE, Simpson GR, Denyer M, McGrath SE, Falgari G, Killick E, Eeles R, Stebbing J, Pchejetski D, Cutress R, Murray N, Michael A, Pandha H. Annels NE, et al. Among authors: mcgrath se. Clin Exp Immunol. 2014 Aug;177(2):428-38. doi: 10.1111/cei.12332. Clin Exp Immunol. 2014. PMID: 24654775 Free PMC article.

6

EN2 in Prostate Cancer.

McGrath SE, Michael A, Morgan R, Pandha H. McGrath SE, et al. Adv Clin Chem. 2015;71:47-76. doi: 10.1016/bs.acc.2015.06.002. Epub 2015 Jul 21. Adv Clin Chem. 2015. PMID: 26411411 Review.

7

Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.

McGrath SE, Annels N, Madhuri TK, Tailor A, Butler-Manuel SA, Morgan R, Pandha H, Michael A. McGrath SE, et al. BMC Cancer. 2018 Oct 3;18(1):943. doi: 10.1186/s12885-018-4816-5. BMC Cancer. 2018. PMID: 30285763 Free PMC article.

8

Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience.

Battisti NML, Rogerson F, Lee K, Shepherd S, Mohammed K, Turner N, McGrath S, Okines A, Parton M, Johnston S, Allen M, Ring A. Battisti NML, et al. Among authors: mcgrath s. Cancer Treat Res Commun. 2020;24:100188. doi: 10.1016/j.ctarc.2020.100188. Epub 2020 Jun 27. Cancer Treat Res Commun. 2020. PMID: 32619830 Free article.

9

Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.

Cunningham N, Shepherd S, Mohammed K, Lee KA, Allen M, Johnston S, Kipps E, McGrath S, Noble J, Parton M, Ring A, Turner NC, Okines AFC. Cunningham N, et al. Among authors: mcgrath s. Breast Cancer Res Treat. 2022 Oct;195(3):333-340. doi: 10.1007/s10549-022-06703-3. Epub 2022 Aug 17. Breast Cancer Res Treat. 2022. PMID: 35976513 Free PMC article.

10

Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer.

Angelis V, Tippu Z, Joshi K, Reis S, Gronthoud F, Fribbens C, Okines A, Stanway S, Cottier E, McGrath S, Watkins D, Noble J, Bhosle J, Gerlinger M, Hamid I, Soliman H, Nenclares P, Jones R, Harrington K, Gennatas S. Angelis V, et al. Among authors: mcgrath s. Eur J Cancer. 2020 Sep;136:99-106. doi: 10.1016/j.ejca.2020.06.027. Epub 2020 Jul 7. Eur J Cancer. 2020. PMID: 32659475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters